Kestra Medical Technologies, Ltd.
corporate_fare Company Profile
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 12 items for KMTS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 12 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for KMTS spans 10-Q, 8-K, 10-K, 144.
Recent high-impact activity:
- ASSURE Defibrillator Study Meets Endpoints; All 303 Shock Events Converted
- Kestra 10-Q Reveals Material Weaknesses in Financial Controls Alongside 60% Revenue Growth
- Kestra Medical Delivers 60% Revenue Growth and Lifts FY27 Guidance to $141M
- Kestra Medical Lifts FY27 Revenue Outlook to $141M
- Kestra FY26 Revenue Jumps 59% to $95M, Guides FY27 at $137M; Refinances Debt with $200M Term Loan
Financial Snapshot
Short Interest & Short Volume
8.15 days to coverFINRA reported short interest of 4,104,243 shares in KMTS as of the October 30, 2026 settlement, a 19.7% increase from the prior period — about 8.2 days to cover at its recent average daily volume. On November 19, 2026, 72.1% of KMTS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.